News from

News Archive

Every story published by Penn Today—all in one place.
Reset All Filters
7391 Results
Promising inhibitor combination for hard-to-treat leukemia subtypes
Andres Blanco in a lab at Penn Vet.

Andrés Blanco is an assistant professor of biomedical science at Penn’s School of Veterinary Medicine.

(Image: John Donges)

Promising inhibitor combination for hard-to-treat leukemia subtypes

Researchers from Penn Vet and other institutions have identified a novel inhibitor combination of molecules that induce terminal differentiation for the treatment of human non-APL subtypes of AML.

From Penn Vet

2 min. read

Exploring inflation and economics through the lens of history
Melissa Teixeira stands in front of a conference room speaking to students.

Melissa Teixeira discusses the final assignment with her Inflationary Times history class.

nocred

Exploring inflation and economics through the lens of history

In Inflationary Times, a history course from Melissa Teixeira, students grappled with big-picture concepts of debt, money, and currency across the globe and through time.

4 min. read

Generative AI can help doctors diagnose patients—but is it biased?

Generative AI can help doctors diagnose patients—but is it biased?

A new study by Annnenberg School for Communication professor Damon Centola tests if AI tools could help improve medical care without increasing bias. The findings suggest that “AI can meaningfully augment physician decision-making without introducing inequities in clinical decisions,” Centola says.

Collaborating with southern Black grandmothers to reimagine scholarship
Staci L. Jones.

Image: Kyle Cassidy/Annenberg School for Communication

Collaborating with southern Black grandmothers to reimagine scholarship

For an Annenberg School for Communication dissertation, Staci L. Jones and four grandmother co-authors introduce the Kitchen Scholar Framework. Their work embraces knowledge that goes beyond academia.

3 min. read

Soon-to-be-graduate hopes to deliver primary care to rural communities
Chip Chambers stands on college campus.

nocred

Soon-to-be-graduate hopes to deliver primary care to rural communities

Fueled by his faith, Chip Chambers, a fifth-year M.D./M.B.A. student in the Perelman School of Medicine and Wharton School, has always looked for ways to serve.“My faith is a huge motivator of everything that I do. I just believe that I’ve been blessed with a lot of things that I didn’t earn and that I have a responsibility to steward those for the good of other people and not for myself,” Chambers says.

4 min. read

Q&A: The first American pope
The new pope, Pope Leo, waves from St. Peter’s Basilica.

Pope Leo XIV at St. Peter’s Basilica after being chosen the 267th pontiff of the Roman Catholic Church on May 8.

(Image: AP Photo/Alessandra Tarantino)

  • Q&A

    • Q&A: The first American pope

    Melissa Wilde of the Department of Sociology, whose research has led her to the Vatican Secret Archive, among other places, discusses the new Pope Leo XIV, the first American pontiff, and the implications for the Roman Catholic Church.

    3 min. read

    Enhanced CAR T cell therapy offers new strategy for lymphoma
    3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

    Image: iStock/Naeblys

    Enhanced CAR T cell therapy offers new strategy for lymphoma

    A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

    2 min. read

    First new subtype of Castleman disease discovered in 45 years
    David Fajgenbaum in his lab.

    David Fajgenbaum is an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and associate director of patient impact in the Penn Orphan Disease Center. He also leads the Castleman Disease Research Program.

    (Image: Courtesy of Penn Medicine)

    First new subtype of Castleman disease discovered in 45 years

    A new study co-authored by Penn Medicine’s David Fajgenbaum expands the spectrum of the rare disorder, which will help diagnose and treat patients caught between existing classification systems.

    2 min. read